InvestorsHub Logo
icon url

steel8000

11/20/20 11:28 AM

#21301 RE: Work Harder #21300

The more I read your fantastic dd the more I think mymx is extremely Valuable $$$$$$
icon url

bow-tie

11/20/20 11:35 AM

#21302 RE: Work Harder #21300

Barney S. Graham, M.D., Ph.D.
Achievements and Future Challenges in the
Surveillance of Respiratory Viruses
San Jose, Costa Rica
January 30, 2013
https://www.sabin.org/sites/sabin.org/files/Barney%20S.%20Graham.pdf

DS-Cav1
AAAAI Mar2014 HO
aaaai.confex.com/aaaai/2014/webprogram/Handout...
Mymetics RSV Mymetics VLP-Virosome Multiple Elderly patients Pre-clinical ... DS-Cav1 Cubic pH 9.5 DS-Cav1 Cubic pH 5.5 V207L S190F S155C-S290C V207L S190F V207L

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152492960
https://www.niaid.nih.gov/research/barney-graham-md-phdhttps://www.nih.gov/news-events/news-releases/respiratory-syncytial-virus-vhttps://investorshub.advfn.com/boards/read_msg.aspx?message_id=152799044accine-enters-clinical-testing



icon url

bow-tie

11/20/20 12:14 PM

#21305 RE: Work Harder #21300

The tiny tweak behind COVID-19 vaccines
Prepandemic coronavirus research by Jason McLellan and Barney Graham led to a trick for stabilizing the prefusion form of spike proteins
by Ryan Cross
SEPTEMBER 29, 2020 | APPEARED IN VOLUME 98, ISSUE 38
The tiny tweak behind COVID-19 vaccines
cen.acs.org/pharmaceuticals/vaccines/tiny-tweak...
Jason McLellan holding a 3-D printed structure of the SARS-CoV-2 spike protein ... That molecule, called DS-Cav1 and published in Science in 2013 (DOI: 10.1126/science.1243283), induced 10 times ...
https://cen.acs.org/pharmaceuticals/vaccines/tiny-tweak-behind-COVID-19/98/i38


Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
1Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA.
2Department of Chemical Engineering, University of Texas, Austin, TX 78712, USA.
3Department of Oncology, Dell Medical School, University of Texas, Austin, TX 78712, USA.
4Center for Systems and Synthetic Biology, University of Texas, Austin, TX 78712, USA.
?*Corresponding author. Email: maynard@che.utexas.edu (J.A.M.); ilya@finkelsteinlab.org (I.J.F.); jmclellan@austin.utexas.edu (J.S.M.)
Hide authors and affiliations
Science 18 Sep 2020:
Vol. 369, Issue 6510, pp. 1501-1505
DOI: 10.1126/science.abd0826
https://science.sciencemag.org/content/369/6510/1501.full



Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
Referred to by
Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Kenny Roose, Loes van Schie, Markus Hoffmann, Stefan Pöhlmann, Barney S. Graham, Nico Callewaert, Bert Schepens, Xavier Saelens, Jason S. McLellan

1
Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA
2
VIB-UGent Center for Medical Biotechnology, VIB, 9052 Ghent, Belgium
3
Department of Biochemistry and Microbiology, Ghent University, 9052 Ghent, Belgium
4
Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium
5
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
6
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA
7
Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, 37077 Göttingen, Germany
8
Faculty of Biology and Psychology, University Göttingen, 37077 Göttingen, Germany
Received 25 March 2020, Revised 14 April 2020, Accepted 17 April 2020, Available online 5 May 2020.

Published: May 5, 2020; corrected online: May 28, 2020

https://www.sciencedirect.com/science/article/pii/S0092867420304943